In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

HOUSTON - Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company with a market capitalization of $3.1 million, has announced continued progress in its clinical trials for cancer treatments.

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Considering taking supplements to treat endometrial cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of endometrial cancer. Follow the links to read common ...

While part 1A (dose escalation) determined the recommended dose of INCB123667 for expansion and the maximum tolerated dose ...